LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.031667
 23.10 84.90 6 1616 0.0037 -0.4639
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 23.10 84.90 1836 1616 1.1360 1.0609
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 24.81 84.90 1423 1769 0.8042 0.9030
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 24.81 84.90 1615 1769 0.9127 0.9587
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 24.81 84.90 7 1769 0.0040 -0.4342
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 24.81 84.90 1967 1769 1.1116 1.0489
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 26.51 84.90 1521 1923 0.7909 0.8984
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 26.51 84.90 1696 1923 0.8819 0.9449
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 26.51 84.90 10 1923 0.0052 -0.3782
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 26.51 84.90 2070 1923 1.0763 1.0330
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 28.21 84.90 1673 2091 0.7999 0.9057
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 28.21 84.90 1801 2091 0.8611 0.9363
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 28.21 84.90 303 2091 0.1449 0.3168
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 28.21 84.90 2263 2091 1.0820 1.0344
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.92 84.90 1772 2237 0.7919 0.9035
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.92 84.90 1934 2237 0.8643 0.9391
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.92 84.90 1639 2237 0.7324 0.8723
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.92 84.90 2418 2237 1.0806 1.0331
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 31.62 84.90 1895 2449 0.7736 0.8969
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 31.62 84.90 2070 2449 0.8450 0.9318
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 31.62 84.90 2002 2449 0.8172 0.9185
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 31.62 84.90 2664 2449 1.0875 1.0349
MN20160318_Q02
I11
MCF 10A-H2B-mCherry Dasatinib
0.031667
 33.32 84.90 1994 2722 0.7324 0.8793
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 33.32 84.90 2194 2722 0.8059 0.9156
MN20160318_Q02
E06
MCF 10A-H2B-mCherry Dasatinib
0.031667
 33.32 84.90 2567 2722 0.9429 0.9766
MN20160318_Q02
I11